I’ve worked in the biotech industry for over 20 years and specifically in antibody discovery and engineering for the past 15 years. One thing I’ve noticed over the years is that many commercial antibodies simply don’t do what they advertise. This is so common that many times I’d order two different antibodies because there was a good chance that one of them wouldn’t work. It’s the “buy and pray” model of retailing. The most common problems I encountered are antibodies that don’t have the advertised species cross-reactivity or antibodies that bound to additional proteins besides what’s on the label. This is especially the case when dealing with antibodies to a protein that’s within a family of related proteins. For example, you buy an antibody for CEACAM5, but what you don’t realize (until too late) is that it also binds to CEACAMs 1, 3 and 7. This can be very costly in both money and time lost. Researchers shouldn’t take this as a given in the industry.
Another thing I’ve noticed over the years at the bench is that I’ve been involved in making extraordinary antibodies working along with very talented people. I don’t know how many times I said to myself, “wow, scientists would just love to be able to purchase this antibody” following the discovery and characterization of a new antibody. So, after being burned many times by poor reagents, I will be generating and selling my own line of recombinant antibodies that will have features never before seen in the retail market. I'm going to start small (just myself) and bootstrap my way with my own funding and grow organically. I've got a great little lab in Redmond, WA.
Welcome to Cobalt Biologics. I’m probably not going to have anything for sale for some time while I build my platform and perform initial discovery and characterization. Please be patient – I will have really cool reagents that you can trust coming in the near future! Please contact me if you have requests, ideas, or want to collaborate.
Founder and CEO